Recordati S.p.A. | Ownership
Companies that own Recordati S.p.A.
Fidelity Management & Research Co.
5,119,169
2.45%
3,254,753
0.02%
07/31/2018
Norges Bank Investment Management
3,208,617
1.53%
-674,899
0.02%
12/31/2017
The Vanguard Group, Inc.
2,570,791
1.23%
27,377
0%
07/31/2018
BNP Paribas Asset Management France SAS
2,135,502
1.02%
73,388
0.12%
07/31/2018
BlackRock Fund Advisors
1,613,567
0.77%
2,274
0%
09/06/2018
State Street Global Advisors Ltd.
1,095,575
0.52%
-41,221
0.04%
09/06/2018
Baring Asset Management Ltd.
1,080,992
0.52%
-69,904
0.5%
10/31/2017
Grantham, Mayo, Van Otterloo & Co. LLC
1,027,337
0.49%
91,323
0.1%
05/31/2018
Amundi Asset Management SA (Investment Management)
909,573
0.44%
-1,109
0.05%
08/29/2018
Montanaro Asset Management Ltd.
793,000
0.38%
98,000
1.23%
07/31/2018
| Address |
Via Matteo Civitali, 1
Milan Milan 20148
Italy
|
|
Employees
|
- |
| Website |
http://www.recordati.it |
| Updated |
09/14/2018 |
| Recordati SpA engages in the research, development, manufacturing and marketing of pharmaceuticals. It operates through two segments: Pharmaceutical and Rare Diseases. The Pharmaceutical segment offers prescription and over-the-counter products as well as chemical syntheses, intermediates, and active ingredients for its proprietary and licensed brands. |
